Payment overview · 2025
General Payments
$373.07
21 reported records · 7 companies
Healthcare provider profile · identity verified
Michael Bazel, MD
Allopathic & Osteopathic Physicians|Emergency Medicine · BELL, CA · NPI 1598712978
Verified facts
What the public records show
CMS Open Payments records show Michael Bazel, MD received $373.07 in general payments during 2025 across 21 reported records.
Electronic Waveform Lab, Inc. accounted for 25.4% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 7 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Trelegy Ellipta, Zenpep.
Aimmune Therapeutics, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ZENPEP as an associated drug or biological on 32144 records involving 12432 distinct recipient NPIs. Public Medicare Part D data also shows 25 claims for Zenpep by this doctor in 2024.
Amgen Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported PROLIA as an associated drug or biological on 20867 records involving 11744 distinct recipient NPIs. Public Medicare Part D data also shows 23 claims for Prolia by this doctor in 2024.
GlaxoSmithKline, LLC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported TRELEGY ELLIPTA as an associated drug or biological on 131532 records involving 37148 distinct recipient NPIs. Public Medicare Part D data also shows 158 claims for Trelegy Ellipta by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Electronic Waveform Lab, Inc. | Unresolved — no canonical attribution shown | $94.86 | 25.4% | 10 | 2025 |
| GlaxoSmithKline, LLC. | Unresolved — no canonical attribution shown | $84.23 | 22.6% | 3 | 2025 |
| Abbott Laboratories | Unresolved — no canonical attribution shown | $63.10 | 16.9% | 1 | 2025 |
| Amgen Inc. | Unresolved — no canonical attribution shown | $58.85 | 15.8% | 3 | 2025 |
| SHIELD THERAPEUTICS INC | Unresolved — no canonical attribution shown | $36.87 | 9.9% | 2 | 2025 |
| Eisai Inc. | Unresolved — no canonical attribution shown | $17.92 | 4.8% | 1 | 2025 |
| Aimmune Therapeutics, Inc. | Unresolved — no canonical attribution shown | $17.24 | 4.6% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $373.07 | 21 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| TRELEGY ELLIPTA Normalized: trelegy ellipta |
Drug | GlaxoSmithKline, LLC. | $84.23 | 3 | 2025 |
Source payment records
|
|||||
| ID NOW INSTRUMENT Normalized: id now instrument |
Device | Abbott Laboratories | $63.10 | 1 | 2025 |
Source payment records
|
|||||
| OTEZLA Normalized: otezla |
Drug | Amgen Inc. | $58.85 | 3 | 2025 |
Source payment records
|
|||||
| REPATHA Normalized: repatha |
Biological | Amgen Inc. | $58.85 | 3 | 2025 |
Source payment records
|
|||||
| ACCRUFER Normalized: accrufer |
Drug | SHIELD THERAPEUTICS INC | $36.87 | 2 | 2025 |
Source payment records
|
|||||
| Leqembi Normalized: leqembi |
Drug | Eisai Inc. | $17.92 | 1 | 2025 |
Source payment records
|
|||||
| ZENPEP Normalized: zenpep |
Drug | Aimmune Therapeutics, Inc. | $17.24 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| TRELEGY ELLIPTA trelegy ellipta |
2025 | Trelegy Ellipta | 2024 | 158 | exact normalized | Medicare Part D |
| ZENPEP zenpep |
2025 | Zenpep | 2024 | 25 Beneficiary count suppressed |
exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Aimmune Therapeutics, Inc. Exact reporting entity; no affiliate inference |
2025 | ZENPEP open payments reported associated product |
CMS Open Payments — General Payments 32144 supporting records · 12432 recipient NPIs · example record 1249641927 |
Zenpep · 2024 Exact normalized brand match · 1 Part D row |
25 | suppressed by CMS |
| Amgen Inc. Exact reporting entity; no affiliate inference |
2025 | PROLIA open payments reported associated product |
CMS Open Payments — General Payments 20867 supporting records · 11744 recipient NPIs · example record 1226874448 |
Prolia · 2024 Exact normalized brand match · 1 Part D row |
23 | 15 |
| GlaxoSmithKline, LLC. Exact reporting entity; no affiliate inference |
2025 | TRELEGY ELLIPTA open payments reported associated product |
CMS Open Payments — General Payments 131532 supporting records · 37148 recipient NPIs · example record 1190332369 |
Trelegy Ellipta · 2024 Exact normalized brand match · 1 Part D row |
158 | 23 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Omeprazole-Sodium Bicarbonate | Omeprazole/Sodium Bicarbonate | 2548 | 262 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 2021 | 203 |
| Amlodipine Besylate | Amlodipine Besylate | 1692 | 174 |
| Vascepa | Icosapent Ethyl | 1621 | 199 |
| Atorvastatin Calcium | Atorvastatin Calcium | 1568 | 165 |
| Gabapentin | Gabapentin | 1534 | 169 |
| Ezetimibe | Ezetimibe | 1514 | 143 |
| Losartan Potassium | Losartan Potassium | 1251 | 134 |
| Diflorasone Diacetate | Diflorasone Diacetate | 1189 | 121 |
| Meclizine Hcl | Meclizine Hcl | 1068 | 122 |
| Donepezil Hcl | Donepezil Hcl | 1039 | 98 |
| Metformin Er Gastric | Metformin Hcl | 1034 | 105 |
| Furosemide | Furosemide | 939 | 93 |
| Escitalopram Oxalate | Escitalopram Oxalate | 929 | 94 |
| Alendronate Sodium | Alendronate Sodium | 925 | 87 |
| Zileuton Er | Zileuton | 915 | 97 |
| Fenofibrate | Fenofibrate | 871 | 95 |
| Allopurinol | Allopurinol | 839 | 97 |
| Tamsulosin Hcl | Tamsulosin Hcl | 839 | 82 |
| Ibuprofen | Ibuprofen | 817 | 132 |
| Carvedilol | Carvedilol | 792 | 75 |
| Clonidine Hcl | Clonidine Hcl | 785 | 83 |
| Metoprolol Succinate | Metoprolol Succinate | 783 | 78 |
| Levothyroxine Sodium | Levothyroxine Sodium | 774 | 78 |
| Hydrochlorothiazide | Hydrochlorothiazide | 744 | 70 |
| Omeprazole | Omeprazole | 703 | 90 |
| Sumatriptan Succ-Naproxen Sod | Sumatriptan Succ/Naproxen Sod | 668 | 57 |
| Baclofen | Baclofen | 658 | 69 |
| Lofena | Diclofenac Potassium | 650 | 80 |
| Memantine Hcl | Memantine Hcl | 600 | 59 |
| Icosapent Ethyl | Icosapent Ethyl | 589 | 127 |
| Diclofenac Sodium | Diclofenac Sodium | 569 | 95 |
| Lactulose | Lactulose | 563 | 67 |
| Rivastigmine | Rivastigmine | 562 | 53 |
| Metoprolol Tartrate | Metoprolol Tartrate | 544 | 56 |
| Januvia | Sitagliptin Phosphate | 543 | 63 |
| Nitroglycerin | Nitroglycerin | 516 | 52 |
| Dihydroergotamine Mesylate | Dihydroergotamine Mesylate | 510 | 66 |
| Memantine Hcl Er | Memantine Hcl | 494 | 52 |
| Dexlansoprazole Dr | Dexlansoprazole | 476 | 59 |
| Linzess | Linaclotide | 433 | 61 |
| Metformin Hcl | Metformin Hcl | 429 | 53 |
| Fluticasone Propionate | Fluticasone Propionate | 424 | 54 |
| Tavaborole | Tavaborole | 422 | 67 |
| Sertraline Hcl | Sertraline Hcl | 408 | 46 |
| Ventolin Hfa | Albuterol Sulfate | 401 | 50 |
| Meloxicam | Meloxicam, Submicronized | 398 | 39 |
| Clopidogrel | Clopidogrel Bisulfate | 391 | 40 |
| Lisinopril | Lisinopril | 389 | 41 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 373 | 39 |
| Hydrocortisone Butyrate | Hydrocortisone Butyrate | 369 | 36 |
| Chlorzoxazone | Chlorzoxazone | 362 | 43 |
| Celecoxib | Celecoxib | 350 | 41 |
| Ketoconazole | Ketoconazole | 348 | 48 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 348 | 35 |
| Zolpidem Tartrate | Zolpidem Tartrate | 339 | 72 |
| Meloxicam | Meloxicam | 331 | 56 |
| Montelukast Sodium | Montelukast Sodium | 328 | 38 |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 320 | 36 |
| Creon | Lipase/Protease/Amylase | 316 | 43 |
| Tolmetin Sodium | Tolmetin Sodium | 305 | 87 |
| Duloxetine Hcl | Duloxetine Hcl | 300 | 26 |
| Glipizide | Glipizide | 300 | 28 |
| Famotidine | Famotidine | 299 | 33 |
| Ozempic | Semaglutide | 292 | 47 |
| Colchicine | Colchicine | 271 | 31 |
| Hydralazine Hcl | Hydralazine Hcl | 271 | 30 |
| Jardiance | Empagliflozin | 271 | 35 |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 267 | 31 |
| Simvastatin | Simvastatin | 263 | 29 |
| Trazodone Hcl | Trazodone Hcl | 263 | 34 |
| Hydrocortisone | Hydrocortisone | 251 | 53 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 250 | 45 |
| Lidocaine | Lidocaine | 246 | 38 |
| Alprazolam | Alprazolam | 234 | 37 |
| Naproxen-Esomeprazole Mag | Naproxen/Esomeprazole Mag | 227 | 27 |
| Eliquis | Apixaban | 217 | 27 |
| Myrbetriq | Mirabegron | 216 | 29 |
| Tramadol Hcl | Tramadol Hcl | 215 | 41 |
| Atenolol | Atenolol | 213 | 23 |
| Glimepiride | Glimepiride | 205 | 22 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 200 | 28 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 199 | 34 |
| Repatha Sureclick | Evolocumab | 198 | 33 |
| Propranolol Hcl | Propranolol Hcl | 191 | 22 |
| Azelastine Hcl | Azelastine Hcl | 179 | 20 |
| Janumet | Sitagliptin Phos/Metformin Hcl | 178 | 22 |
| Valsartan | Valsartan | 173 | 18 |
| Nifedipine Er | Nifedipine | 171 | 22 |
| Sumatriptan Succinate | Sumatriptan Succinate | 171 | 20 |
| Potassium Chloride | Potassium Chloride | 170 | 22 |
| Olmesartan-Amlodipine-Hctz | Olmesartan/Amlodipin/Hcthiazid | 159 | 18 |
| Single Use Swab | Alcohol Antiseptic Pads | 158 | 22 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 158 | 23 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 157 | 23 |
| Frovatriptan Succinate | Frovatriptan Succinate | 156 | 15 |
| Oxybutynin Chloride | Oxybutynin Chloride | 156 | 15 |
| Clonidine | Clonidine | 153 | 17 |
| Buspirone Hcl | Buspirone Hcl | 151 | 12 |
| Nebivolol Hcl | Nebivolol Hcl | 149 | 16 |
| Clotrimazole | Clotrimazole | 147 | 20 |
| Lorazepam | Lorazepam | 147 | 27 |
| Azithromycin | Azithromycin | 145 | 122 |
| Farxiga | Dapagliflozin Propanediol | 138 | 18 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 137 | 18 |
| Procto-Med Hc | Hydrocortisone | 137 | 17 |
| Finasteride | Finasteride | 135 | 12 |
| Diclofenac Potassium | Diclofenac Potassium | 133 | 29 |
| Cilostazol | Cilostazol | 131 | 12 |
| Dutasteride | Dutasteride | 131 | 15 |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 131 | 13 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 130 | 23 |
| Naproxen | Naproxen | 129 | 19 |
| Spironolactone | Spironolactone | 129 | 11 |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 127 | 12 |
| Benazepril Hcl | Benazepril Hcl | 126 | 12 |
| Febuxostat | Febuxostat | 125 | 17 |
| Gemtesa | Vibegron | 125 | 21 |
| Alcohol Prep Pads | Alcohol Antiseptic Pads | 118 | 29 |
| Trulicity | Dulaglutide | 118 | 13 |
| Aripiprazole | Aripiprazole | 116 | suppressed |
| Telmisartan | Telmisartan | 116 | suppressed |
| Mounjaro | Tirzepatide | 111 | 20 |
| Clonazepam | Clonazepam | 110 | 20 |
| Paroxetine Hcl | Paroxetine Hcl | 109 | 11 |
| Synthroid | Levothyroxine Sodium | 108 | 13 |
| Ciclopirox | Ciclopirox | 106 | 21 |
| Digoxin | Digoxin | 105 | 11 |
| Mometasone Furoate | Mometasone Furoate | 104 | 11 |
| Brilinta | Ticagrelor | 102 | 11 |
| Fluoxetine Hcl | Fluoxetine Hcl | 101 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 100 | suppressed |
| Ranolazine Er | Ranolazine | 99 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 97 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 94 | 14 |
| Ciclopirox | Ciclopirox Olamine | 93 | suppressed |
| Easy Touch Alcohol Prep Pads | Alcohol Antiseptic Pads | 92 | 20 |
| Quetiapine Fumarate | Quetiapine Fumarate | 88 | suppressed |
| Xarelto | Rivaroxaban | 88 | 13 |
| Ramipril | Ramipril | 86 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 84 | 11 |
| Mirtazapine | Mirtazapine | 83 | suppressed |
| Trintellix | Vortioxetine Hydrobromide | 83 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 81 | suppressed |
| Glipizide Er | Glipizide | 80 | suppressed |
| Methimazole | Methimazole | 80 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 79 | 13 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 79 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 76 | suppressed |
| Alcohol Swabs | Alcohol Antiseptic Pads | 75 | 19 |
| Risedronate Sodium | Risedronate Sodium | 74 | suppressed |
| Ibandronate Sodium | Ibandronate Sodium | 73 | suppressed |
| Lansoprazole | Lansoprazole | 73 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 71 | 14 |
| Pantoprazole Sodium | Pantoprazole Sodium | 71 | 14 |
| Restasis | Cyclosporine | 71 | 12 |
| Cyclobenzaprine Hcl Er | Cyclobenzaprine Hcl | 70 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 70 | 59 |
| Pravastatin Sodium | Pravastatin Sodium | 68 | suppressed |
| Lurasidone Hcl | Lurasidone Hcl | 66 | suppressed |
| Ondansetron Odt | Ondansetron | 65 | 15 |
| Praluent Pen | Alirocumab | 64 | 13 |
| Synjardy | Empagliflozin/Metformin Hcl | 64 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 63 | 11 |
| Ibu | Ibuprofen | 63 | 15 |
| Jentadueto | Linagliptin/Metformin Hcl | 62 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 61 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 61 | 15 |
| Loperamide | Loperamide Hcl | 61 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 60 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 58 | suppressed |
| Pitavastatin Calcium | Pitavastatin Calcium | 57 | suppressed |
| Fesoterodine Fumarate Er | Fesoterodine Fumarate | 56 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 54 | suppressed |
| Mupirocin | Mupirocin | 54 | 15 |
| Prasugrel Hcl | Prasugrel Hcl | 54 | suppressed |
| Diclofenac Epolamine | Diclofenac Epolamine | 52 | suppressed |
| Gemfibrozil | Gemfibrozil | 52 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 52 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 51 | suppressed |
| Pregabalin | Pregabalin | 51 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 51 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 51 | suppressed |
| Cyclosporine | Cyclosporine | 50 | suppressed |
| Entresto | Sacubitril/Valsartan | 49 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 49 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 49 | suppressed |
| Novolog Mix 70-30 Flexpen | Insulin Aspart Prot/Insuln Asp | 47 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 47 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 46 | suppressed |
| Edarbyclor | Azilsartan Med/Chlorthalidone | 45 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 45 | suppressed |
| Rybelsus | Semaglutide | 44 | suppressed |
| Novolog Flexpen | Insulin Aspart | 43 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 41 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 40 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 40 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 39 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 39 | suppressed |
| Betamethasone Dipropionate | Betamethasone Dipropionate | 38 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 38 | 30 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 37 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 37 | suppressed |
| Irbesartan | Irbesartan | 37 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 37 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 37 | suppressed |
| Dexilant | Dexlansoprazole | 35 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 35 | suppressed |
| Niacin Er | Niacin | 35 | suppressed |
| Tacrolimus | Tacrolimus | 35 | suppressed |
| Tribenzor | Olmesartan/Amlodipin/Hcthiazid | 35 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 34 | 32 |
| Trihexyphenidyl Hcl | Trihexyphenidyl Hcl | 34 | suppressed |
| Ofloxacin | Ofloxacin | 33 | 15 |
| Repatha Syringe | Evolocumab | 33 | suppressed |
| Latanoprost | Latanoprost | 32 | suppressed |
| Tradjenta | Linagliptin | 32 | suppressed |
| Dapagliflozin | Dapagliflozin Propanediol | 31 | suppressed |
| Temazepam | Temazepam | 31 | suppressed |
| Ultra-Fine Nano Pen Needle | Pen Needle, Diabetic | 31 | suppressed |
| Edarbi | Azilsartan Medoxomil | 30 | suppressed |
| Novolin R | Insulin Regular, Human | 30 | suppressed |
| Belsomra | Suvorexant | 28 | suppressed |
| Chlorthalidone | Chlorthalidone | 27 | suppressed |
| Glipizide-Metformin | Glipizide/Metformin Hcl | 27 | suppressed |
| Amoxicillin | Amoxicillin | 26 | 24 |
| Fluocinonide | Fluocinonide | 26 | suppressed |
| Lubiprostone | Lubiprostone | 26 | suppressed |
| Roflumilast | Roflumilast | 26 | suppressed |
| Comfort Ez Pen Needle | Pen Needle, Diabetic | 25 | suppressed |
| Mitigare | Colchicine | 25 | suppressed |
| Nateglinide | Nateglinide | 25 | suppressed |
| Potassium Citrate Er | Potassium Citrate | 25 | suppressed |
| Zenpep | Lipase/Protease/Amylase | 25 | suppressed |
| Amlodipine-Olmesartan | Amlodipine Bes/Olmesartan Med | 24 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 24 | suppressed |
| Irbesartan-Hydrochlorothiazide | Irbesartan/Hydrochlorothiazide | 24 | suppressed |
| Novofine 32 | Pen Needle, Diabetic | 24 | suppressed |
| Sulindac | Sulindac | 24 | suppressed |
| Exelon | Rivastigmine | 23 | suppressed |
| Insulin Syringe | Syringe-Needle,insulin,0.5 Ml | 23 | suppressed |
| Levetiracetam | Levetiracetam | 23 | suppressed |
| Olanzapine | Olanzapine | 23 | suppressed |
| Prolia | Denosumab | 23 | 15 |
| Alcohol Pads | Alcohol Antiseptic Pads | 22 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 22 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 22 | suppressed |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 22 | suppressed |
| Ibuprofen-Famotidine | Ibuprofen/Famotidine | 21 | suppressed |
| Levemir Flexpen | Insulin Detemir | 21 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 20 | suppressed |
| Nexium | Esomeprazole Magnesium | 19 | suppressed |
| Ultra-Fine Micro Pen Needle | Pen Needle, Diabetic | 19 | suppressed |
| Clarithromycin | Clarithromycin | 18 | 17 |
| Colesevelam Hcl | Colesevelam Hcl | 18 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 17 | suppressed |
| Ssd | Silver Sulfadiazine | 17 | suppressed |
| Tadalafil | Tadalafil | 17 | suppressed |
| Corlanor | Ivabradine Hcl | 16 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 16 | suppressed |
| Insulin Syringe | Syring-Needl,disp,insul,0.3 Ml | 16 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 16 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 16 | suppressed |
| Santyl | Collagenase Clostridium Hist. | 16 | suppressed |
| Silver Sulfadiazine | Silver Sulfadiazine | 16 | suppressed |
| Advair Diskus | Fluticasone Propion/Salmeterol | 15 | suppressed |
| Carbamazepine | Carbamazepine | 15 | suppressed |
| Theophylline Er | Theophylline Anhydrous | 15 | suppressed |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 14 | suppressed |
| Benazepril-Hydrochlorothiazide | Benazepril/Hydrochlorothiazide | 14 | suppressed |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 14 | suppressed |
| Dulera | Mometasone/Formoterol | 14 | suppressed |
| Erythromycin | Erythromycin Base | 14 | suppressed |
| Humulin 70-30 | Insulin Nph Hum/Reg Insulin Hm | 14 | suppressed |
| Nabumetone | Nabumetone | 14 | suppressed |
| Neomycin-Polymyxin-Dexameth | Neomycin/Polymyxin B/Dexametha | 14 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 14 | suppressed |
| Propafenone Hcl Er | Propafenone Hcl | 14 | suppressed |
| Sucralfate | Sucralfate | 14 | suppressed |
| Trospium Chloride | Trospium Chloride | 14 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 14 | suppressed |
| Amlodipine-Valsartan | Amlodipine Besylate/Valsartan | 13 | suppressed |
| Arnuity Ellipta | Fluticasone Furoate | 13 | suppressed |
| Atrovent Hfa | Ipratropium Bromide | 13 | suppressed |
| Avodart | Dutasteride | 13 | suppressed |
| Dilt-Xr | Diltiazem Hcl | 13 | suppressed |
| Ezetimibe-Simvastatin | Ezetimibe/Simvastatin | 13 | suppressed |
| Imipramine Hcl | Imipramine Hcl | 13 | suppressed |
| Nystatin | Nystatin | 13 | suppressed |
| Repaglinide | Repaglinide | 13 | suppressed |
| Soliqua 100-33 | Insulin Glargine/Lixisenatide | 13 | suppressed |
| Timolol Maleate | Timolol Maleate | 13 | suppressed |
| Tobradex | Tobramycin/Dexamethasone | 13 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 13 | suppressed |
| Verapamil Er | Verapamil Hcl | 13 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 13 | suppressed |
| Amcinonide | Amcinonide | 12 | suppressed |
| Anastrozole | Anastrozole | 12 | suppressed |
| Benicar | Olmesartan Medoxomil | 12 | suppressed |
| Desoximetasone | Desoximetasone | 12 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 12 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 12 | suppressed |
| Flecainide Acetate | Flecainide Acetate | 12 | suppressed |
| Humalog | Insulin Lispro | 12 | suppressed |
| Neupro | Rotigotine | 12 | suppressed |
| Novolog | Insulin Aspart | 12 | suppressed |
| Pradaxa | Dabigatran Etexilate Mesylate | 12 | suppressed |
| Proscar | Finasteride | 12 | suppressed |
| Rexulti | Brexpiprazole | 12 | suppressed |
| Selenium Sulfide | Selenium Sulfide | 12 | suppressed |
| Terbinafine Hcl | Terbinafine Hcl | 12 | suppressed |
| Tretinoin | Tretinoin | 12 | suppressed |
| Breyna | Budesonide/Formoterol Fumarate | 11 | suppressed |
| Clindamycin Phosphate | Clindamycin Phosphate | 11 | suppressed |
| Crestor | Rosuvastatin Calcium | 11 | suppressed |
| Diltiazem 24hr Er (Xr) | Diltiazem Hcl | 11 | suppressed |
| Glyburide-Metformin Hcl | Glyburide/Metformin Hcl | 11 | suppressed |
| Ketoprofen | Ketoprofen | 11 | suppressed |
| Multaq | Dronedarone Hcl | 11 | suppressed |
| Paliperidone Er | Paliperidone | 11 | suppressed |
| Rasagiline Mesylate | Rasagiline Mesylate | 11 | suppressed |
| Rivastigmine | Rivastigmine Tartrate | 11 | suppressed |
| Steglatro | Ertugliflozin Pidolate | 11 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 11 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $373.07 · 21 records | Electronic Waveform Lab, Inc. | ACCRUFER, ID NOW INSTRUMENT, Leqembi, OTEZLA, REPATHA, TRELEGY ELLIPTA, ZENPEP | 3 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Trelegy Ellipta play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with Aimmune Therapeutics, Inc.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error